Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag Fujirebio and Eisai partner to develop blood tests for diagnosing Alzheimer's and other neurodegenerative diseases.

flag Fujirebio and Eisai have agreed to collaborate on research and development of blood-based biomarkers for diagnosing neurodegenerative diseases, including Alzheimer's. flag They plan to develop and commercialize diagnostic tools for proteins like p-Tau217 and simplify diagnostic methods. flag This partnership aims to enhance global access to new diagnostic technologies, improving disease diagnosis and treatment.

5 Articles